← FDA Drug Approvals (Drugs@FDA)

ANDA213235

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2025-07-21

Drug application

FDA Application #
ANDA213235
Application type
Abbreviated New Drug Application (Generic)
Brand name
—
Generic name
—
Active ingredients
—
Dosage form
—
Route
—
Marketing status
—
Sponsor
GLENMARK PHARMS LTD
First approval
2025-07-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown